Pharmaceutical composition for therapy of interstitial cystitis

Abstract

A depressant of capsaicin-sensitive sensory nerve, containing quinuclidin-3′-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a salt thereof as an active ingredient, specifically a therapeutic drug of interstitial cystitis, hypersensitive disorder of the lower urinary tract, and/or abacterial prostatitis.

1 - 5 . (canceled) 
   
   
       6 . A method of treating a patient suffering from interstitial cystitis, comprising administering to the patient a therapeutically effective amount of quinuclidin-3′-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a pharmaceutically acceptable salt thereof. 
   
   
       7 . The method according to  claim 6 , in which an oral preparation is administered. 
   
   
       8 . A method of treating a patient suffering from a hypersensitivity disorder of the lower urinary tract, comprising administering to the patient a therapeutically effective amount of quinuclidin-3′-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a pharmaceutically acceptable salt thereof. 
   
   
       9 . The method according to  claim 8 , in which an oral preparation is administered. 
   
   
       10 . A method of treating a patient suffering from abacterial prostatitis, comprising administering to the patient a therapeutically effective amount of quinuclidin-3′-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a pharmaceutically acceptable salt thereof. 
   
   
       11 . The method according to  claim 10 , in which an oral preparation is administered.